Meet Jessica Grossman, IgGenix Founder — Bio + How to Reach Out

Last updated: 2025-11-08

Who is Jessica Grossman?

Dr. Jessica Grossman is the CEO of IgGenix, a biotechnology company focused on developing therapies for people with food allergies and other severe allergic conditions. She has over two decades of experience in the medical, pharmaceutical, and biotechnology fields. Dr. Grossman is dedicated to advancing science through leading businesses and non-for-profits.

Jessica Grossman's Work History

Prior to joining IgGenix, Dr. Grossman served as CEO of Medicines360. She has also held positions as CEO and President of Sense4Baby, Inc., and Medical Director at Ethicon Endo-Surgery, a Johnson & Johnson company. Dr. Grossman has also founded and led other companies.

• Dec 2020 - Chief Executive Officer, IgGenix, Inc
• Jul 2015 - Dec 2020 - Chief Executive Officer, Medicines360
• Feb 2013 - Mar 2014 - CEO and President, Sense4Baby, Inc.
• Nov 2010 - Feb 2013 - Medical Director, Medical Affairs, Ethicon Endo-Surgery, Johnson and Johnson

Jessica Grossman's Education

Dr. Grossman holds a Bachelor of Arts in Biology and English from Brandeis University and a Doctor of Medicine from Thomas Jefferson University.

• Thomas Jefferson University - MD in Medicine (1994 - 1998)
• Brandeis University - MA in English and Biology (1990 - 1994)

About IgGenix

IgGenix is a biotechnology company taking a revolutionary approach to directly address allergic disease. The company is developing first-in-class therapies for people limited by food allergies and other severe allergic conditions by re-engineering key antibodies involved in the allergic cascade.

IgGenix Funding

IgGenix has raised $25 million in Series A1 funding and $40M Series B financing.

How to Reach Jessica Grossman?

You can reach Jessica Grossman at *******@iggenix.com or by calling +1 **********. To get Jessica Grossman's contact information and other startup founders like this, sign up for a free account at Anybody.com.